Vera Therapeutics Inc’s filing revealed that its PRESIDENT AND CEO Fordyce Marshall unloaded Company’s shares for reported $0.75 million on Dec 18 ’24. In the deal valued at $43.07 per share,17,500 shares were sold. As a result of this transaction, Fordyce Marshall now holds 85,942 shares worth roughly $3.6 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MARSHALL FORDYCE bought 17,500 shares, generating $768,425 in total proceeds.
Before that, Fordyce Marshall sold 17,500 shares. Vera Therapeutics Inc shares valued at $821,523 were divested by the PRESIDENT AND CEO at a price of $46.94 per share. As a result of the transaction, Fordyce Marshall now holds 85,942 shares, worth roughly $3.6 million.
Wells Fargo initiated its Vera Therapeutics Inc [VERA] rating to an Overweight in a research note published on November 21, 2024; the price target was $70. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid October with a ‘”a Sector outperform”‘ rating. Oppenheimer began covering VERA with “an Outperform” recommendation on January 25, 2024. Cantor Fitzgerald started covering the stock on January 08, 2024. It rated VERA as “an Overweight”.
Price Performance Review of VERA
On Tuesday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock fall -0.92% to $41.92. Over the last five days, the stock has lost -4.53%. Vera Therapeutics Inc shares have risen nearly 172.56% since the year began. Nevertheless, the stocks have risen 164.48% over the past one year. While a 52-week high of $51.61 was reached on 11/13/24, a 52-week low of $14.20 was recorded on 01/19/24. SMA at 50 days reached $45.14, while 200 days put it at $40.77.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 41.35, which if violated will result in even more drops to 40.79. On the upside, there is a resistance level at 42.46. A further resistance level may holdings at 43.00. The Relative Strength Index (RSI) on the 14-day chart is 35.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.88%. Stochastics %K at 16.11% indicates the stock is a buying.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2024-11-29, growing by 0.13 million shares to a total of 6.52 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 6.39 million shares. There was a rise of 1.99%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 18, 2023 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $29 price target.
